Medical News

RSS

Amrubicin promise for etoposide-naïve SCLC patients

Patients with chemotherapy-refractory small-cell lung cancer may benefit from treatment with the topoisomerase II inhibitor amrubicin, research from Japan suggests.

12 May 2014

PhotoMedex revenues decrease 12% to $50.1 million in first quarter 2014

PhotoMedex, Inc. reports financial results for the three months ended March 31, 2014 and announces LCA-Vision stockholder approval of PhotoMedex's previously announced acquisition of all outstanding shares of LCA-Vision, a leading provider of laser vision correction services under the LasikPlus brand.

12 May 2014

GE Capital's Healthcare Financial Services provides $9 million term loan to Cerapedics

GE Capital's Healthcare Financial Services business has provided a $9 million term loan to Cerapedics, Inc., a privately-held medical device company based in Westminster, CO. The funds will be used to support Cerapedics' general business operations, including the advancement of its U.S. regulatory process.

12 May 2014

Perrigo receives final approval from FDA for azelastine hydrochloride nasal spray ANDA

Perrigo Company plc announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%).

12 May 2014

Sports Authority, MRA partner to educate public about melanoma

Sports Authority, one of the nation's largest full-line sporting goods retailers, today announced that they have partnered with the Melanoma Research Alliance, the largest private funder of melanoma research, to inform the public about this deadly form of skin cancer and to raise funds to support studies aimed at its treatment and cure. This is the fourth consecutive year Sports Authority has participated in and supported the effort.

12 May 2014

Abeona Therapeutics obtains FDA Orphan Drug Designations for Sanfilippo Syndrome therapies

Abeona Therapeutics, a start-up company created around intellectual property licensed from Nationwide Children's Hospital to develop treatments for Sanfilippo Syndrome Types A and B, has been granted Orphan Drug Designations for its lead investigational therapies by the U.S. Food and Drug Administration Office of Orphan Products Development.

12 May 2014

Esaote gets FDA clearance to market Virtual Navigator fusion imaging technology for ultrasound

Esaote North America announced today that it has received FDA clearance to market and sell its Virtual Navigator fusion imaging technology for ultrasound.

12 May 2014

Political cartoon: 'Failure To Launch?'

Kaiser Health News provides a fresh take on health policy developments with "Failure To Launch?" by Gary McCoy.

12 May 2014

Valley General Hospital to replace AS/400 based product with Stockell Healthcare's InsightCS system

Stockell Healthcare Systems is pleased to announce that Valley General Hospital, a full-service community hospital located in Monroe, Washington, has selected the company's InsightCS Revenue Cycle Information system.

12 May 2014

NPS MedicineWise welcomes ABC’s decision to take down Catalyst program on statins, heart disease

NPS MedicineWise has welcomed the ABC’s ruling — published today — that its Catalyst program aired in October 2013 on statins and heart disease breached its own standards on impartiality.

12 May 2014

Syneron Candela looks at latest non-invasive body shaping technologies

Join Syneron Candela for an extraordinary look at the latest non-invasive body shaping technologies on May 31, 2014 with renowned plastic surgeon Stephen Mulholland, MD.

12 May 2014

Quintiles agrees to acquire Encore Health Resources

As part of its continued efforts to strengthen and expand its service capabilities across the healthcare continuum, Quintiles today announced that it has signed an agreement to acquire Encore Health Resources.

12 May 2014

Leadless pacemaker technology shows promising performance after 12 months

Vivek Reddy, MD, Director of Arrhythmia Services for The Mount Sinai Hospital, reported his promising12-month follow-up data showing the world's first leadless pacemaker is demonstrating overall device performance comparable to conventional pacemakers. Dr. Reddy presented the one-year LEADLESS study data findings during his late-breaking clinical trial presentation on May 9 at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions in San Francisco, CA.

12 May 2014

Akebia Therapeutics reports net loss of $9.7 million for Q1 2014

Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, today announced financial results for the first quarter ended March 31, 2014.

12 May 2014

Results from Sorin Group's study on Freedom Solo presented at AATS 2014

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, is proud to announce the results of its trial on the Freedom Solo for approval on the US market presented at the 94th Annual Meeting of American Association for Thoracic Surgery in Toronto, Canada.

12 May 2014

Foundation Medicine obtains CE mark for FoundationOne

Foundation Medicine, Inc. today announced that it has obtained a CE mark for FoundationOne®. The CE mark allows FoundationOne to be placed on the market in the European Economic Area.

12 May 2014

State highlights: N.Y. Medicaid change and cash; Conn. mental health cops; Conn. mental health school outreach

A selection of health policy stories from New York, Connecticut and Minnesota. When Hurricane Sandy flooded two adult homes in Queens, hundreds of disabled, elderly or mentally ill residents were caught in the surge.

12 May 2014

Verastem announces expansion of ongoing COMMAND study in Japan

Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the expansion of its ongoing COMMAND study to include clinical trial sites in Japan.

12 May 2014

Aratana initiates pivotal field effectiveness study for AT-001

Aratana Therapeutics, Inc., a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion animals, today announced the initiation of the pivotal field effectiveness study for AT-001 (grapiprant), the company's innovative drug for treating pain in dogs with osteoarthritis.

12 May 2014

Hospital patients now see improved quality of nutrition health care by CMS’ new rule

Hospital patients may now see improved quality and timeliness of nutrition health care and hospitals will save hundreds of millions of dollars annually because of a new rule issued by the Centers for Medicare and Medicaid Services, according to the Academy of Nutrition and Dietetics.

12 May 2014

Medical News

Amrubicin promise for etoposide-naïve SCLC patients

PhotoMedex revenues decrease 12% to $50.1 million in first quarter 2014

GE Capital's Healthcare Financial Services provides $9 million term loan to Cerapedics

Perrigo receives final approval from FDA for azelastine hydrochloride nasal spray ANDA

Sports Authority, MRA partner to educate public about melanoma

Abeona Therapeutics obtains FDA Orphan Drug Designations for Sanfilippo Syndrome therapies

Esaote gets FDA clearance to market Virtual Navigator fusion imaging technology for ultrasound

Political cartoon: 'Failure To Launch?'

Valley General Hospital to replace AS/400 based product with Stockell Healthcare's InsightCS system

NPS MedicineWise welcomes ABC’s decision to take down Catalyst program on statins, heart disease

Syneron Candela looks at latest non-invasive body shaping technologies

Quintiles agrees to acquire Encore Health Resources

Leadless pacemaker technology shows promising performance after 12 months

Akebia Therapeutics reports net loss of $9.7 million for Q1 2014

Results from Sorin Group's study on Freedom Solo presented at AATS 2014

Foundation Medicine obtains CE mark for FoundationOne

State highlights: N.Y. Medicaid change and cash; Conn. mental health cops; Conn. mental health school outreach

Verastem announces expansion of ongoing COMMAND study in Japan

Aratana initiates pivotal field effectiveness study for AT-001

Hospital patients now see improved quality of nutrition health care by CMS’ new rule

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News